Wegovy 1.7mg

Wegovy 1.7 mg is a prescription, once-weekly subcutaneous injection used for long-term weight management and reducing cardiovascular risks. It contains the active ingredient semaglutide, a GLP-1 receptor agonist that mimics natural hormones to regulate appetite and slow stomach emptying. This specific 1.7 mg dose is a late-stage escalation step, typically taken during month 4 of the treatment schedule